Latest filing published 30 Jul 2026 for AtriCure, Inc., €211k.
Justin J. Noznesky is a declared insider of AtriCure, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 63 filings cover trades dated from 1 March 2016 to 29 July 2026.
Every open-market trade on record is a sale: 21 sales worth €6.0M. Outside the open market, there are 32 share grants and 4 option exercises. 2026 to date brings no purchases and 1 sale.
The record was last updated on 30 July 2026 with an open-market sale (€211k) in AtriCure, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 63 declarations